Page results
-
An international clinical trial testing a novel cancer immunotherapy which may prevent skin cancer from recurring has recruited its first patients at UCLH.
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
-
A minimally invasive technique for treating prostate cancer has been used for the first time in the NHS at UCLH. It can be used with precision to treat the affected area, reducing side effects.
-
The spring/summer edition of Charity Matters is out now.
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
Men currently attending a hospital outpatient clinic for prostate hormone injections every 3 or 6 months will be advised that (unless not clinically appropriate) their next injection will be administered at a local GP practice, usually by the practice nurse.
-
All semen analysis referrals should be made via the NHS e-Referral Service (e-RS). We will no longer be able to book semen analysis appointments through direct requests from patients or GP surgeries via email.
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
UCLH is delighted that His Majesty King Charles III has accepted the patronages of University College Hospital and the Royal London Hospital for Integrated Medicine.
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
File results
-
FOI/2024/0228 - Radiology Information Systems (RIS) software
-
FOI/2024/0230 - Physician Associate/ Anaesthesia Associate prescribing medication 2022/23-2023/24
-
FOI/2024/0232 - Freedom of Information requests and staffing 2020/21-2022/23
-
FOI/2024/0238 - Haematology and immunoglobulin treatments
-
FOI/2024/0243 - Pathology laboratory service/ information system at Trust
-
FOI/2024/0246 - Gastric and gastro-oesophageal/ non-small cell lung/ renal cell carcinoma cancer treatments
-
FOI/2024/0254 - Urothelial and endometrial cancer treatments
-
FOI/2024/0255 - Ingenica stock management system in theatres
-
FOI/2024/0259 - Clinical attachments for international medical graduates
-
FOI/2024/0263 - Longest wait for ophthalmology pathway treatment